ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?
Distal DVT: Should we treat?

More Related Content

Editor's Notes

  • #2: Title: DVT: Should we treat?
  • #4: The old days: a DVT
  • #5: This was not a DVT
  • #8: Venography
  • #11: What McLeod said about Doppler USS
  • #14: NICE – serial above knee recommendation
  • #15: Should we treat calf DVT?
  • #16: USS: Whole leg - data
  • #19: Other evidence for prognosis of calf DVT
  • #20: Superficial thrombophlebitis – anticoag evidence
  • #21: ACT trial
  • #22: Other evidence for treating calf DVT
  • #23: Risk stratification of calf DVT – D-dimer, etc.
  • #24: Risk stratification of anticoag – figures for risk
  • #25: NOACs
  • #30: What would I do?
  • #31: Shared decision making?
  • #32: Dan Horner, Kerstin Hogg
  • #33: Summary